RPRX Annual Current Liabilities
$161.38 M
-$1.01 B-86.17%
31 December 2023
Summary:
As of January 21, 2025, RPRX annual total current liabilities is $161.38 million, with the most recent change of -$1.01 billion (-86.17%) on December 31, 2023. During the last 3 years, it has fallen by -$146.51 million (-47.59%). RPRX annual current liabilities is now -86.17% below its all-time high of $1.17 billion, reached on December 31, 2022.RPRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Quarterly Current Liabilities
$1.17 B
+$892.06 M+323.56%
30 September 2024
Summary:
As of January 21, 2025, RPRX quarterly total current liabilities is $1.17 billion, with the most recent change of +$892.06 million (+323.56%) on September 30, 2024. Over the past year, it has increased by +$1.04 billion (+837.40%). RPRX quarterly current liabilities is now -0.38% below its all-time high of $1.17 billion, reached on June 30, 2023.RPRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.2% | +837.4% |
| 3 y3 years | -47.6% | +837.4% |
| 5 y5 years | -72.2% | - |
RPRX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.2% | at low | -0.4% | +837.4% |
| 5 y | 5-year | -86.2% | at low | -0.4% | +837.4% |
| alltime | all time | -86.2% | at low | -0.4% | +837.4% |
Royalty Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.17 B(+323.6%) |
| June 2024 | - | $275.70 M(+121.3%) |
| Mar 2024 | - | $124.57 M(-22.8%) |
| Dec 2023 | $161.38 M(-86.2%) | $161.38 M(+26.1%) |
| Sept 2023 | - | $127.93 M(-89.1%) |
| June 2023 | - | $1.17 B(+5.0%) |
| Mar 2023 | - | $1.12 B(-4.3%) |
| Dec 2022 | $1.17 B | $1.17 B(+3.1%) |
| Sept 2022 | - | $1.13 B(+520.7%) |
| June 2022 | - | $182.33 M(+34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $135.87 M(-20.7%) |
| Dec 2021 | $171.25 M(-44.4%) | $171.25 M(-32.9%) |
| Sept 2021 | - | $255.06 M(-10.2%) |
| June 2021 | - | $283.99 M(+10.9%) |
| Mar 2021 | - | $255.98 M(-16.9%) |
| Dec 2020 | $307.89 M(-7.7%) | $307.89 M(+14.0%) |
| Sept 2020 | - | $269.98 M(-40.1%) |
| June 2020 | - | $450.97 M(+3.9%) |
| Mar 2020 | - | $433.96 M(+30.2%) |
| Dec 2019 | $333.42 M(-42.5%) | $333.42 M |
| Dec 2018 | $580.17 M | - |
FAQ
- What is Royalty Pharma annual total current liabilities?
- What is the all time high annual current liabilities for Royalty Pharma?
- What is Royalty Pharma annual current liabilities year-on-year change?
- What is Royalty Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Royalty Pharma?
- What is Royalty Pharma quarterly current liabilities year-on-year change?
What is Royalty Pharma annual total current liabilities?
The current annual current liabilities of RPRX is $161.38 M
What is the all time high annual current liabilities for Royalty Pharma?
Royalty Pharma all-time high annual total current liabilities is $1.17 B
What is Royalty Pharma annual current liabilities year-on-year change?
Over the past year, RPRX annual total current liabilities has changed by -$1.01 B (-86.17%)
What is Royalty Pharma quarterly total current liabilities?
The current quarterly current liabilities of RPRX is $1.17 B
What is the all time high quarterly current liabilities for Royalty Pharma?
Royalty Pharma all-time high quarterly total current liabilities is $1.17 B
What is Royalty Pharma quarterly current liabilities year-on-year change?
Over the past year, RPRX quarterly total current liabilities has changed by +$1.04 B (+837.40%)